Zydus subsidiary wins big relief as GST demand drops sharply

Regulatory & Legal View source PDF Explain this filing

ZYDUSLIFE · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-0.6%Reaction day

₹1103.40

prior close

₹1109.50

announcement price

After-mkt

timing

Nifty 100market · index membership as recorded later (tracked since Jun 2026)-0.3%-0.3% vs market

Pharmaceuticals peers, median of 164sector-0.6%+0.0% vs sector

On the reaction day the stock moved 0.3 pts less than Nifty 100 and in line with its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-0.1

10m

-0.2

15m

-0.1

30m

+0.8

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-0.6-0.3-0.3-0.6+0.0

Next day

+0.4-0.7+1.1-1.4+1.8

-0.0+1.3-1.4-0.1+0.1

-1.5+2.6-4.1+0.4-1.8

-2.0+3.1-5.2+0.1-2.1

-3.7+3.6-7.2+0.1-3.8

-2.8+3.3-6.2+0.4-3.2

15d

-0.2+3.9-4.1+3.9-4.1

+4.3+4.0+0.2+4.2+0.1

+1.4+6.0-4.6+4.9-3.5

+1.3+1.5-0.2+8.7-7.4

UpDownMarket · Nifty 100Sector · Pharmaceuticals peers, median of 164Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Zydus Healthcare Limited, a wholly owned subsidiary, received favorable orders from the Chhattisgarh Appellate Authority on GST Input Tax Credit disputes for FY 2018-19 and FY 2019-20. For FY 2018-19, demand dropped from Rs 28.7 lakhs to Rs 0.24 lakhs. For FY 2019-20, demand dropped from Rs 13.2 lakhs to Rs 0.20 lakhs. Most of the original demand and penalty has been set aside.

Likely market impact

Positive outcome - nearly full relief on GST demand, saving cash outflow for the subsidiary.